FI821579L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
FI821579L
FI821579L FI821579A FI821579A FI821579L FI 821579 L FI821579 L FI 821579L FI 821579 A FI821579 A FI 821579A FI 821579 A FI821579 A FI 821579A FI 821579 L FI821579 L FI 821579L
Authority
FI
Finland
Prior art keywords
formula
pharmaceutical composition
substituents
optionally bearing
pharmaceutically
Prior art date
Application number
FI821579A
Other languages
English (en)
Other versions
FI821579A0 (fi
Inventor
David Robert Brittain
Robin Wood
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI821579A0 publication Critical patent/FI821579A0/fi
Publication of FI821579L publication Critical patent/FI821579L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI821579A 1981-05-12 1982-05-05 Farmaceutiska kompositioner FI821579L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8114397 1981-05-12

Publications (2)

Publication Number Publication Date
FI821579A0 FI821579A0 (fi) 1982-05-05
FI821579L true FI821579L (fi) 1982-11-13

Family

ID=10521723

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821579A FI821579L (fi) 1981-05-12 1982-05-05 Farmaceutiska kompositioner

Country Status (25)

Country Link
US (2) US4478847A (fi)
EP (1) EP0065407B1 (fi)
JP (1) JPS57192314A (fi)
KR (1) KR830009775A (fi)
AT (1) ATE12113T1 (fi)
AU (1) AU561390B2 (fi)
CA (1) CA1182823A (fi)
DD (1) DD202576A5 (fi)
DE (1) DE3262529D1 (fi)
DK (1) DK203882A (fi)
ES (2) ES8306485A1 (fi)
FI (1) FI821579L (fi)
GR (1) GR75871B (fi)
HU (1) HU186016B (fi)
IE (1) IE53102B1 (fi)
IL (1) IL65604A (fi)
MW (1) MW1982A1 (fi)
NO (1) NO821557L (fi)
NZ (1) NZ200576A (fi)
PH (1) PH18101A (fi)
PL (1) PL236283A1 (fi)
PT (1) PT74876B (fi)
ZA (1) ZA822797B (fi)
ZM (1) ZM3282A1 (fi)
ZW (1) ZW7882A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU566869B2 (en) * 1982-05-11 1987-11-05 Imperial Chemical Industries Plc Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
GB8331194D0 (en) * 1982-12-20 1983-12-29 Ici Plc Chemical process
JPS60142984A (ja) * 1983-12-28 1985-07-29 Kyorin Pharmaceut Co Ltd 新規なスピロピロリジン−２，５−ジオン誘導体およびその製造法
US4567278A (en) * 1984-03-26 1986-01-28 Imperial Chemical Industries Plc Process for racemizing certain spiro compounds
GB8415635D0 (en) * 1984-06-19 1984-07-25 Ici Plc Cyclic amides
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity
US4900739A (en) * 1988-10-20 1990-02-13 American Home Products Corp. Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US4946858A (en) * 1988-10-20 1990-08-07 American Home Products Corporation Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CN1596100A (zh) * 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 可食用组合物及含可食用外壳的制剂
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
KR101333861B1 (ko) * 2005-05-24 2013-11-28 메르크 세로노 에스. 에이. Ｃｒｔｈ２ 조정자로서 삼환계 스피로 유도체
US20080057023A1 (en) * 2006-08-29 2008-03-06 Chynn Emil W Oxygenated ophthalmic composition
WO2009026240A1 (en) * 2007-08-17 2009-02-26 Solexel, Inc. Methods for liquid transfer coating of three-dimensional substrates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4177230A (en) * 1978-06-02 1979-12-04 The United States Of America As Represented By The Secretary Of The Air Force Process for producing reaction sintered silicon nitride of increased density
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides

Also Published As

Publication number Publication date
IE820928L (en) 1982-11-12
AU561390B2 (en) 1987-05-07
FI821579A0 (fi) 1982-05-05
ES8402840A1 (es) 1984-03-01
AU8299482A (en) 1982-11-18
PT74876B (en) 1983-12-07
PL236283A1 (en) 1983-09-12
DE3262529D1 (en) 1985-04-18
ZM3282A1 (en) 1982-12-21
ZA822797B (en) 1983-07-27
DD202576A5 (de) 1983-09-21
GR75871B (fi) 1984-08-02
DK203882A (da) 1982-11-13
IE53102B1 (en) 1988-06-22
NZ200576A (en) 1984-11-09
KR830009775A (ko) 1983-12-23
ES519780A0 (es) 1984-03-01
US4478847A (en) 1984-10-23
EP0065407B1 (en) 1985-03-13
ATE12113T1 (de) 1985-03-15
IL65604A (en) 1986-12-31
US4523021A (en) 1985-06-11
MW1982A1 (en) 1984-02-08
EP0065407A3 (en) 1983-03-16
PH18101A (en) 1985-03-20
JPS57192314A (en) 1982-11-26
ZW7882A1 (en) 1983-11-30
HU186016B (en) 1985-05-28
NO821557L (no) 1982-11-15
EP0065407A2 (en) 1982-11-24
CA1182823A (en) 1985-02-19
ES512093A0 (es) 1983-06-01
ES8306485A1 (es) 1983-06-01
PT74876A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
FI821579L (fi) Farmaceutiska kompositioner
FI803539L (fi) Substituerade indolin-2-on derivater
ATE11049T1 (de) Aktive pharmazeutische spirohydantoinderivate.
NO833528L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutan-derivater
ES8407050A1 (es) Un derivado de trifluormetil-espiro(imidazolidina-4,3'-indolina)-2,2'5-triona.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC